In line with these findings, Ki67+ proliferating tumor cells were substantially increased in Ctrl and Gem groups, whereas they were reduced in IBRD9 and IBRD9 + Gem–treated tumors (Figure 3G and H), suggesting a potential additive effect of BRD9 in controlling primary tumor growth. The gene discussed is MKI67; the disease is neoplasm.